Delivery Order SPE2DB22D1106-SPE2DB25FFBR9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,259.34 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open...
- The Defense Logistics Agency awarded a delivery order valued at $1,746.15 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 ml pharmaceutical product on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $2,283.33 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,396.92 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product. This firm fixed-price delivery order, issued on July 24, 2025, represents a non-competitive set-aside award and is scheduled for completion by July 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $13,604.02 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $4,198.91 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL medication, with performance to be completed by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $21,466.53 delivery order to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open...
- The Defense Logistics Agency awarded a delivery order valued at $2,499.03 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 ml, a human growth hormone medication. The contract, issued on July 21, 2025, with completion targeted for July 22, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $22,018.26 to AmerisourceBergen Drug Corp for Norditropin Flexpro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The contract specifies performance at the vendor's corporate office location in...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,012.68 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. AmerisourceBergen,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBR9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,634.98 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Norditropin FlexPro is a human growth hormone therapeutic product, aligning with AmerisourceBergen Drug Corp's extensive portfolio of specialty medications and brand-name pharmaceuticals distributed across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 8/5/25 |